Today we’re putting the spotlight on Joe Cursons, PhD, who recently stepped up into the role of Vice President, Computational Biology.
A bioengineer by trade, Joe has extensive experience in applying computational methods to identify and develop novel drug targets in oncology, making him an integral part of the oNKo-Innate team. Leading our computational biology group, Joe’s prowess in the analysis of next-generation sequencing data has been key in the development of our major pipeline assets, allowing us to better understand tumour progression and the complex cancer-immunity cycle.
More importantly, he has a demonstrated track record of leading teams that have moved immune-oncology targets from discovery research into clinical trials.
Working closely with our functional genomics and Biotherapeutics teams, Joe is the glue that holds our programs together and drives them forward. He’s shown incredible initiative and leadership, generating new ideas and implementing new technologies to advance our pipeline assets toward the clinic.
As VP, Computational Biology, Joe will continue to work with our CTO and CSO, formulating the best strategic direction for drug discovery programs to ensure we’re able to deliver on our promise of creating novel cancer immunotherapies.
Congratulations, Joe! Thank you for bringing your depth of knowledge, high-level technical expertise, and incredible dedication to the team – we’re lucky to have you.